Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 277

1.

Efficacy and tolerability of memantine in the treatment of dementia.

Rossom R, Adityanjee, Dysken M.

Am J Geriatr Pharmacother. 2004 Dec;2(4):303-12. Review.

PMID:
15903287
3.

Pharmacotherapeutic approaches to the treatment of Alzheimer's disease.

Standridge JB.

Clin Ther. 2004 May;26(5):615-30. Review.

PMID:
15220008
4.
6.

Memantine in the treatment of mild-to-moderate Alzheimer's disease.

Cosman KM, Boyle LL, Porsteinsson AP.

Expert Opin Pharmacother. 2007 Feb;8(2):203-14. Review.

PMID:
17257090
7.

Alzheimer's disease and the glutamate NMDA receptor.

Doraiswamy PM.

Psychopharmacol Bull. 2003 Spring;37(2):41-9. Review.

PMID:
14566213
9.
11.

[The clinical relevance of memantine use].

Sobów T.

Psychiatr Pol. 2004 Mar-Apr;38(2):321-30. Review. Polish.

PMID:
15307296
12.

Memantine for dementia.

Areosa SA, Sherriff F.

Cochrane Database Syst Rev. 2003;(3):CD003154. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD003154.

PMID:
12917950
14.

Memantine.

Jarvis B, Figgitt DP.

Drugs Aging. 2003;20(6):465-76; discussion 477-8. Review.

PMID:
12710865
15.

Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: a randomized, double-blind, placebo-controlled trial.

Porsteinsson AP, Grossberg GT, Mintzer J, Olin JT; Memantine MEM-MD-12 Study Group..

Curr Alzheimer Res. 2008 Feb;5(1):83-9.

PMID:
18288936
16.

Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date.

Bullock R.

Alzheimer Dis Assoc Disord. 2006 Jan-Mar;20(1):23-9. Review.

PMID:
16493232
17.

Pooled analyses on cognitive effects of memantine in patients with moderate to severe Alzheimer's disease.

Emre M, Mecocci P, Stender K.

J Alzheimers Dis. 2008 Jun;14(2):193-9.

PMID:
18560130
18.

Is memantine a breakthrough in the treatment of moderate-to-severe Alzheimer's disease?

Doggrell S.

Expert Opin Pharmacother. 2003 Oct;4(10):1857-60. Review.

PMID:
14521495
19.
20.

Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.

Peskind ER, Potkin SG, Pomara N, Ott BR, Graham SM, Olin JT, McDonald S.

Am J Geriatr Psychiatry. 2006 Aug;14(8):704-15.

PMID:
16861375

Supplemental Content

Support Center